MedPAC Eyes Revamped Add-On Reform To Combat High Drug Costs In Part B

By Gabrielle Wanneh / January 25, 2023 at 2:25 PM
Congress’ Medicare Pay advisors are continuing discussions on potential policy options to reduce Part B drug spending, including an option that would eliminate drug add-on pay for providers to incentivize doctors to treat patients with lower cost drugs. The policy is one of three the Medicare Payment Advisory Commission (MedPAC) aims to turn into draft recommendations on reducing Part B drug spending ahead of this year’s June report to Congress. MedPAC staff told commissioners at a Jan. 13 meeting that...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.